What changed?

Epitalon Research & Clinical Development Updates

A sourced timeline of research records and material development changes tracked by BACToBasics for Epitalon. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.

Tracked items

3

Research sources

2

Development entries

1

Latest recorded date

Verified 2026-09-05

Latest development activity

No established modern Phase 1–3 therapeutic program identified.

Verified 2026-09-05 · Preclinical / no established modern program · No established development program

Modern evidence for epitalon is dominated by laboratory, cell, and mechanistic work rather than a validated contemporary clinical-development pathway leading toward regulatory approval.

Open source ↗

Latest research record by publication date

FDA Pharmacy Compounding Advisory Committee — Epitalon Review

Published 2026 · Regulatory · Regulatory evidence review

FDA's 2026 review provides regulatory context for the lack of robust modern human clinical safety and efficacy evidence for Epitalon-related substances.

Open source ↗

Tracked timeline

Research and development record

Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.

Development snapshotVerified 2026-09-05

No established modern Phase 1–3 therapeutic program identified.

Preclinical / no established modern program · No established development program

Modern evidence for epitalon is dominated by laboratory, cell, and mechanistic work rather than a validated contemporary clinical-development pathway leading toward regulatory approval.

Research sourcePublished 2026

FDA Pharmacy Compounding Advisory Committee — Epitalon Review

Regulatory · Regulatory evidence review

FDA's 2026 review provides regulatory context for the lack of robust modern human clinical safety and efficacy evidence for Epitalon-related substances.

Research sourcePublished 2025

Epitalon Increases Telomere Length in Human Cell Lines

Cell / in vitro · Cell / in vitro study

The study reported telomere-related effects in human-derived cell lines and adds mechanistic laboratory evidence for Epitalon.

Follow future Epitalon changes

Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.

Browse all compound updates →Research Library →Clinical Development →

BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.